Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

CPA6 Gene Familial Temporal Lobe Epilepsy Type 5 Genetic Testing in UAE | 2800 AED | DNA Labs UAE

Executive Summary & Core Metrics

  • Diagnostic Accuracy: 99.9% analytical sensitivity via ISO 9001:2015 certified NGS platform with Sanger confirmation of all pathogenic variants.
  • Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM across all UAE emirates.
  • Clinical Oversight: Post-test tele-consultation with a Consultant Medical Geneticist to interpret results within ACMG guidelines and family pedigree context.
  • Insurance Verification: Direct coverage check via WhatsApp at +971 54 548 8731 prior to sample collection.

Test Overview & Methodology

This state-of-the-art genetic test screens the entire CPA6 gene using Next-Generation Sequencing to detect pathogenic variants linked to autosomal dominant familial temporal lobe epilepsy type 5 (FTLE5). Gene analysis covers all coding exons plus flanking intronic regions, with Sanger sequencing confirmation of all clinically significant findings. Results enable precise molecular diagnosis, cascade screening of at-risk relatives, and personalized antiepileptic therapy selection.

Feature DNA Labs UAE CPA6 Test Alternative (Gene Panel or Single-Variant)
Methodology NGS of entire CPA6 coding region + Sanger confirmation Partial gene analysis or targeted genotyping
Turnaround Time 3–4 Weeks 4–8 Weeks (often outsourced)
Price (AED) 2,800 2,500–3,500 (varies by laboratory)

Physician Insight & Safety Protocols

“A positive CPA6 mutation provides a molecular diagnosis that must be correlated with the patient's clinical presentation, EEG findings, and detailed three-generation family pedigree. Our genetic counselling team ensures that every result is interpreted within the framework of ACMG guidelines, enabling informed decisions regarding treatment optimization and cascade screening of at-risk relatives. This test is a powerful tool, but it should complement, not replace, the comprehensive evaluation by your neurologist.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Medication Advisory

Do not discontinue or alter prescribed antiepileptic medication without consulting your treating neurologist. This genetic test provides diagnostic and prognostic information; it does not substitute for acute seizure management or immediate clinical intervention.

Patient FAQ & Clinical Guidance

1. What is the CPA6 gene test for familial temporal lobe epilepsy type 5?

The CPA6 gene test analyzes your DNA for pathogenic mutations linked to autosomal dominant familial temporal lobe epilepsy type 5 (FTLE5). It uses Next-Generation Sequencing to examine all coding regions of the CPA6 gene, identifying variants that may cause or predispose you to focal seizures. A positive result confirms the genetic subtype of epilepsy, helping neurologists tailor antiepileptic therapy and enabling cascade testing in first- and second-degree relatives to identify presymptomatic family members.

2. How do I prepare for the test and what sample is needed?

You can provide a standard whole blood sample collected in an EDTA tube, a single drop of blood on an FTA card, or previously extracted genomic DNA. No fasting is required. Our genetic counsellor will conduct a pre-test tele-session to draw a detailed three-generation family pedigree and explain the implications of possible results. Avoid heavy physical exertion immediately before the blood draw, but continue your regular medications unless your physician advises otherwise.

3. When will I receive results and how are they delivered?

Results are completed within 3 to 4 weeks from sample receipt and are released via a secure patient portal. You will receive a detailed report including the detected variant, its classification according to ACMG/AMP guidelines, and recommendations for clinical correlation. Our genetics team schedules a telephone or video consultation to discuss the findings, their implications for family screening, and neurologist referral pathways.

UAE Regulatory & Data Privacy Adherence

Your genetic data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic results are stored on encrypted servers with access restricted to authorized clinical staff, and no data is shared with third parties without your explicit written consent.

DNA Labs UAE is a DHA-licensed facility (License No. 1143) operating under ISO 9001:2015 quality management standards. All genetic counselling sessions are conducted by licensed medical geneticists registered with the Dubai Health Authority.

Clinical & Logistical Metadata

Test Name CPA6 Gene Familial Temporal Lobe Epilepsy Type 5 (FTLE5) Sequencing
Price (AED) 2,800
Turnaround Time 3–4 Weeks
Sample Type / Matrix Whole Blood (EDTA), FTA Card, or Extracted DNA
Methodology Used Next-Generation Sequencing (NGS) + Sanger Confirmation
ICD-10-CM Code G40.2
LOINC Code 81261-7
DHA Facility License & Laboratory Address License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians